Skip to main content
Figure 8 | BMC Complementary and Alternative Medicine

Figure 8

From: Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized mice

Figure 8

PPC enhanced the IFNγ + /CD8 + T cell response to a dendritic cell vaccine specific for a melanoma antigen. PPC enhanced the dendritic cell vaccine induced production of melanoma associated Trp2-specific IFNγ+/CD8+ T cells. CD8+ T cells were isolated from the splenocytes population and plated with stimulator cells (EL4 only, EL4 pulsed with the Trp2180 peptide, or EL4 pulsed with the irrelevant OVA257 peptide). Mice receiving no PPC are represented by the open bars while those receiving 200 μg/mL PPC ad libitum are represented by the filled bars. Error bars represent the standard deviation. The delivery of PPC was found to significantly enhance the number Trp2180 specific IFNγ+/CD8+ T cells (p = 0.002 for EL4 Trp2180).

Back to article page